Discussion about this post

User's avatar
Bobby Scott, MD's avatar

OpenEvidence truly is a major advance, and it has become much more reliable since it struck the licensing deal with NEJM and JAMA. Of course, it lacks context and you must be cautious when using it to make nuanced clinical decisions. But with the rapidly growing clinical knowledge base, an AI brain is going to be essential

Expand full comment
John T. Brooks's avatar

For professional who present and interpret medical data, should we ask they disclose any financial interests in this data company as form of conflict of interest as is generally requested for investors in pharma?

Expand full comment
5 more comments...

No posts

Ready for more?